基底质内内大麻素和多巴胺之间的相互作用:对帕金森病中的疼痛的影响
Maria Mancini1, Alessandra Calculli1,2, Deborah Di Martino1,2
1Department of Brain and Behavioral Sciences, University of Pavia, c/o Mondino Foundation Via Mondino, 2, Pavia, 27100, Italy.
Journal of anesthesia, analgesia and critical care
|May 14, 2024
概括
内分泌大麻素 (eCBs) 和多巴胺 (DA) 信号交互复杂,影响疼痛感知和缓解. 了解它们的复杂关系,特别是在帕金森病等疾病中,可能会揭示新的疼痛治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 疼痛研究 疼痛研究
- 神经药理学神经药理学
背景情况:
- 基底质回路整合了疼痛的感觉,情感和认知方面.
- 多巴胺 (DA) 信号干扰与慢性疼痛的病原发生有关.
- 内分泌大麻素 (eCBs) 调节多巴胺神经元功能,包括刺激性和突触传播.
研究的目的:
- 探索eCB和DA神经传递之间的相互调节.
- 强调eCB对DAergic神经元中离子和突触信号的作用.
- 分析eCB-DA在疼痛条件中的失衡及其对帕金森病的影响.
主要方法:
- 在疼痛中eCB-DA相互作用的文献综述.
- 对DAergic信号的eCB调制的分析 (CB受体依赖和独立).
- 检查疼痛状态中的eCB-DA系统变化.
主要成果:
- eCB与DA信号产生复杂的适应关系,特别是在DA耗尽后.
- eCBs影响DAergic神经元刺激性和突触功能.
- 在eCB-DA系统的不平衡是疼痛条件的特征.
结论:
- eCB-DA系统在疼痛调节中发挥着重要作用.
- 在帕金森病中降低DA水平与疼痛有关.
- 针对eCB-DA系统提供了新的疼痛治疗方法的潜力.
相关概念视频
Parkinson's Disease: Overview
533
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
533
Parkinson's Disease: Treatment
263
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
263
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Analgesia and Pain Management
584
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
584
Pain
475
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
475
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
231
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
231


